MedPath
FDA Approval

Ezetimibe and Simvastatin

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
January 28, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Ezetimibe(10 mg in 1 1)
Simvastatin(80 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Amneal Pharmaceuticals of New York, LLC

Amneal Pharmaceuticals NY LLC

123797875

Products4

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ezetimibe and Simvastatin

Product Details

NDC Product Code
60219-1158
Application Number
ANDA208831
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
January 28, 2022
EzetimibeActive
Code: EOR26LQQ24Class: ACTIBQuantity: 10 mg in 1 1
Code: AGG2FN16EVClass: ACTIBQuantity: 80 mg in 1 1
BUTYLATED HYDROXYANISOLEInactive
Code: REK4960K2UClass: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QPClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WOClass: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
PROPYL GALLATEInactive
Code: 8D4SNN7V92Class: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT

Ezetimibe and Simvastatin

Product Details

NDC Product Code
60219-1156
Application Number
ANDA208831
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
January 28, 2022
EzetimibeActive
Code: EOR26LQQ24Class: ACTIBQuantity: 10 mg in 1 1
BUTYLATED HYDROXYANISOLEInactive
Code: REK4960K2UClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WOClass: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
Code: AGG2FN16EVClass: ACTIBQuantity: 20 mg in 1 1
PROPYL GALLATEInactive
Code: 8D4SNN7V92Class: IACT
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QPClass: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT

Ezetimibe and Simvastatin

Product Details

NDC Product Code
60219-1155
Application Number
ANDA208831
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
January 28, 2022
EzetimibeActive
Code: EOR26LQQ24Class: ACTIBQuantity: 10 mg in 1 1
Code: AGG2FN16EVClass: ACTIBQuantity: 10 mg in 1 1
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QPClass: IACT
BUTYLATED HYDROXYANISOLEInactive
Code: REK4960K2UClass: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WOClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
PROPYL GALLATEInactive
Code: 8D4SNN7V92Class: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT

Ezetimibe and Simvastatin

Product Details

NDC Product Code
60219-1157
Application Number
ANDA208831
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
January 28, 2022
EzetimibeActive
Code: EOR26LQQ24Class: ACTIBQuantity: 10 mg in 1 1
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QPClass: IACT
Code: AGG2FN16EVClass: ACTIBQuantity: 40 mg in 1 1
BUTYLATED HYDROXYANISOLEInactive
Code: REK4960K2UClass: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WOClass: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
PROPYL GALLATEInactive
Code: 8D4SNN7V92Class: IACT
© Copyright 2025. All Rights Reserved by MedPath